OBS-LIVER-F4407Active studySynthetic mock data
Kenji Tanaka — F4407-LIV-208
Compensated cirrhosis (HCV); LI-RADS 4 nodule · Arm A · enrolled 2024-05-10
Subject ID
s-4407-208
MRN
MRN 6026508
Age / sex
71 / M
ECOG
1
Best response
SD
Σ Δ at Q4
22 mm · +57.1%
nadir +57.1%
RECIST 1.1 — Target lesions
Serial measurements (mm) and per-visit response
Sum-of-diameters; % from baseline (PR ≤ -30%); % from nadir (PD ≥ +20% absolute ≥ 5 mm)
| Lesion | Modality | Baseline2024-06-01 | Q12024-09-01 | Q22024-12-01 | Q32025-03-01 | Q42025-06-01 |
|---|---|---|---|---|---|---|
Liver segment 4 nodule | MRI | 14 | 16 | 18 | 20 | 22 |
| Sum of diameters | mm | 14 | 16 | 18 | 20 | 22 |
| % from baseline | 0.0% | +14.3% | +28.6% | +42.9% | +57.1% | |
| % from nadir | 0.0% | +14.3% | +28.6% | +42.9% | +57.1% | |
| RECIST response | NE | SD | SD | SD | PD |
Non-target lesions
Per-visit qualitative status (presence / absence / equivocal / new)
| Lesion | Baseline | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|---|
| Portal hypertension | present | present | present | present | present |
Other subjects in OBS-LIVER-F4407
s-4407-208
Kenji Tanaka
Arm A · SD
s-4407-271
Fatima Hassan
Arm A · SD
s-4407-302
Theo Romano
Arm A · SD
s-4407-411
Yuki Iversen
Arm A · SD
23 subjects across all studies in workspace.